Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years

23ABC News 2022-10-28

Views 1

Pfizer and BioNTech announced an analysis that showed that their three-dose coronavirus vaccine regimen indicated a strong immune response in children 6 months to 5 years of age. The analysis reported an efficacy rate of more than 80 percent, and what this could mean for the future of vaccinating toddlers.

Share This Video


Download

  
Report form
RELATED VIDEOS